Page last updated: 2024-10-24

candesartan cilexetil and Hyperkalemia

candesartan cilexetil has been researched along with Hyperkalemia in 1 studies

candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects

Hyperkalemia: Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"To retrospectively investigate the effect of carvedilol and spironolactone plus furosemide, administered concomitantly with an angiotensin II converting enzyme inhibitor (ACE-I) or an angiotensin II receptor blocker (ARB) to patients with chronic heart failure (CHF)."7.73Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil. ( Hirooka, K; Nakayama, D; Saito, M; Takada, M; Yasumura, Y, 2006)
"To retrospectively investigate the effect of carvedilol and spironolactone plus furosemide, administered concomitantly with an angiotensin II converting enzyme inhibitor (ACE-I) or an angiotensin II receptor blocker (ARB) to patients with chronic heart failure (CHF)."3.73Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil. ( Hirooka, K; Nakayama, D; Saito, M; Takada, M; Yasumura, Y, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saito, M1
Nakayama, D1
Takada, M1
Hirooka, K1
Yasumura, Y1

Other Studies

1 other study available for candesartan cilexetil and Hyperkalemia

ArticleYear
Carvedilol accelerate elevation of serum potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate or candesartan cilexetil.
    Journal of clinical pharmacy and therapeutics, 2006, Volume: 31, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Benzimidazoles; Biphenyl Compounds; Carbazoles; Carvedilol; Drug The

2006